Pre-treatment tumour perfusion parameters and initial RECIST response do not predict long-term survival outcomes for patients with head and neck squamous cell carcinoma treated with induction chemotherapy.

Pre-treatment tumour perfusion parameters and initial RECIST response do not predict long-term survival outcomes for patients with head and neck squamous cell carcinoma treated with induction chemotherapy.

Previously, we showed that pre-treatment tumour plasma perfusion (Fp) predicts RECIST response to induction chemotherapy (ICT) in locoregionally advanced head and neck squamous cell carcinoma (HNSCC). The aim here was to determine whether the pre-treatment tumour Fp estimate, changes in tumour Fp or...

Full description

Bibliographic Details
Main Authors: Natalie M Lowe, Lucy E Kershaw, Jonathan M Bernstein, Stephanie B Withey, Kathleen Mais, Jarrod J Homer, Nicholas J Slevin, Suzanne C Bonington, Bernadette M Carrington, Catharine M West
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2018-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5874054?pdf=render

Internet

http://europepmc.org/articles/PMC5874054?pdf=render

Similar Items